Research.Patient.info
Advanced Endometrial Cancer research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
A Phase 2 Exploratory, Multicenter, Open-Label Trial to Determine the Safety and Preliminary Clinical Activity of GEN1046 in Combination With Anticancer Agents in Subjects With Advanced Endometrial Cancer
This study is looking into a new treatment for advanced endometrial cancer. It combines a new drug, called DuoBody®-PD-L1x4-1BB, with an existing cancer medicine, KEYTRUDA. Doctors want to see if this combination is safe and if it can shrink tumours.
Italy · Spain · Belgium - recruitingPHASE1
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
This study is testing a new medicine called MOv18 IgE for women with advanced ovarian, endometrial, or triple-negative breast cancer. It aims to find a safe dose and see how well it works, especially in cancers that have a specific marker called Folate Receptor Alpha.
United Kingdom